The molecular biology core seeks to provide center investigators with [1] a centralized resource for oligodeoxynucleotide synthesis, chiefly to facilitate the acquisition of primers for use in polymerase chain reaction amplification, sequencing, and mutagenesis, [2] a library of useful primers, already made and characterized for these purpose, [3] centralized access to a library of useful plasmid constructs, for use in cloning, eukaryotic selection, expression, reporting, and use as reference and control agents, including many proviral plasmids, [4] a central reference resource for quantitation of viral RNA and DNA, including a central reference QC-PCR facility, supplying primers, constructs, and reference reagents and samples, as well as performing assays as a service, and [5] a central data acquisition and sharing of sequence information. In order to accomplish these goals the core proposes: [1] to utilize a dedicated synthesizer for the preparation of oligonucleotides, [2] to perform purification of synthesized oligonucleotides by polyacrylamide gel electrophoresis, [3] to synthesize frequently used primers on a large scale, aliquoting and dispensing these with quality controls, [4] to supply the data analysis core primer information, for dissemination to center investigators, [5] to perform the transformation, preparation and purification of a variety of frequently used plasmids as well as performing custom plasmid preparation on a recharge basis, [6] to maintain secure bacterial and plasmid stocks for center investigators, [7] to perform QC-PCR for genomic and spliced HIV-1 and HIV-2 messages and DNA PCR for provirus with internal standards, providing primers and plasmid constructs for QC-PCR to center investigators, participating in the custom design of QC-PCR systems, as well as standardized samples, samples, and standardized RNA and DNA preparations, on a recharge basis, and [8] sequencing of PCR products for analysis of HIV genomes, on a recharge basis when exceeding funded capability.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI036214-01
Application #
3747625
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Garfein, Richard S; Liu, Lin; Cuevas-Mota, Jazmine et al. (2018) Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerg Infect Dis 24:1806-1815
Heldt, Sven; Prattes, Juergen; Eigl, Susanne et al. (2018) Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect 77:235-241
Jenks, Jeffrey Daniel; Hoenigl, Martin (2018) CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med 3:
Canan, Chelsea E; Chander, Geetanjali; Monroe, Anne K et al. (2018) High-Risk Prescription Opioid Use Among People Living With HIV. J Acquir Immune Defic Syndr 78:283-290
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
White, Cory H; Beliakova-Bethell, Nadejda; Lada, Steven M et al. (2018) Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment. Front Immunol 9:603
Innes, Steve; Patel, Kunjal (2018) Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings. Curr Opin HIV AIDS 13:187-195
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114
Rhodes, Tim (2018) The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential. Soc Sci Med 201:71-79
Morales, Mario; Rafful, Claudia; Gaines, Tommi L et al. (2018) Factors associated with extrajudicial arrest for syringe possession: results of a department-wide survey of municipal police in Tijuana, Mexico. BMC Int Health Hum Rights 18:36

Showing the most recent 10 out of 921 publications